Please assess the completion status of the following clinical trial:

Trial Title: Platelet Rich Plasma Injection Compared With Steroid Injection for the Treatment of Plantar Fasciitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patients having the pain over the plantar aspect of foot for more than 6 weeks with tenderness on palpation over the medial calcaneal tuberosity, failure of conservative treatment with physiotherapy, splints and NSAIDs.~Exclusion Criteria:~* Lumbar radiculopathy~* Existing trauma, previous surgery or any local pathology over the foot~* Patient on aspirin~* Bleeding disorders with low platelet counts~* Systemic disease like diabetes and rheumatoid arthritis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Platelet Rich Plasma (PRP) group (Type: EXPERIMENTAL): The PRP will be prepared based on the Sengodan et al, 2020 study.
- Steroid group (Type: ACTIVE_COMPARATOR): Steroid group will be treated with steroid injection. In this group, 2ml of Inj. Depo-Medrol 80 mg (Methylprednisolone) along with 1 ml lignocaine (0.25%) will be loaded in 5cc syringe and then the cocktail will be injected into medial calcaneal tuberosity at the most tender point using an aseptic technique as mentioned by Nishanth et.at,2018.~After the procedure, participants will be advised not to involve in any kind of rigorous activity with the affected foot for at least two days and then gradually return to their regular activities. All patients will be counseled to follow up in the next visit at 3 months and 6 months. The end-line information will be again recorded at 3 months and 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).